Cargando…

Sars-Cov-2 Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria: An Italian Multicenter Survey

SARS-CoV-2 infection and vaccination have raised concerns in paroxysmal nocturnal hemoglobinuria (PNH). In fact, PNH patients carry an increased infectious risk secondary to complement inhibition treatment or associated bone marrow failure (BMF), and may therefore benefit from preventive strategies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giannotta, Juri Alessandro, Fattizzo, Bruno, Girmenia, Corrado, Ielo, Claudia, Metafuni, Elisabetta, Visentin, Adele, Bianchi, Paola, Apolito, Vincenzo, Beggiato, Eloise, Di Bona, Eros, Sica, Simona, Iori, Anna Paola, Barcellini, Wilma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology. Published by Elsevier Inc. 2021
Materias:	508.Bone Marrow Failure
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701642/ http://dx.doi.org/10.1182/blood-2021-150328

Ejemplares similares

Sars-Cov-2 Infection Associated with Aplastic Anemia and Pure Red Cell Aplasia
por: Lee, Nicholas C.J., et al.
Publicado: (2021)

Acquired Aplastic Anemia in Immunocompetent Pediatric Patients with Asymptomatic COVID-19 Infection: A Case Series
por: Fritch, Jordan E., et al.
Publicado: (2021)

COVID-19 Infection in Patients with Paroxysmal Nocturnal Hemoglobinuria in Italy
por: Barcellini, Wilma, et al.
Publicado: (2020)

Difficult Cases of Paroxysmal Nocturnal Hemoglobinuria: Diagnosis and Therapeutic Novelties
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Paroxysmal Nocturnal Hemoglobinuria in the Context of a Myeloproliferative Neoplasm: A Case Report and Review of the Literature
por: Giannotta, Juri Alessandro, et al.
Publicado: (2021)

Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients
por: Fattizzo, Bruno, et al.
Publicado: (2020)

COVID-19 EM PACIENTE PEDIÁTRICO COM ESFEROCITOSE HEREDITÁRIA
por: Penna, P.S.O.P., et al.
Publicado: (2020)

Managing Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Patient-Focused Perspective
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Transforming growth factor-β signaling modifies the hematopoietic acute inflammatory response to drive bone marrow failure
por: Javier, Jose, et al.
Publicado: (2021)

Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children
por: Gilad, Oded, et al.
Publicado: (2022)

Genotype-phenotype and outcome associations in patients with Fanconi anemia: the National Cancer Institute cohort
por: Altintas, Burak, et al.
Publicado: (2022)

Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia
por: Dong, Peiyuan, et al.
Publicado: (2022)

Somatic genetic alterations predict hematological progression in GATA2 deficiency
por: Largeaud, Laetitia, et al.
Publicado: (2023)

Effects of nandrolone decanoate on telomere length and clinical outcome in patients with telomeropathies: a prospective trial
por: Clé, Diego V., et al.
Publicado: (2022)

Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia
por: Lasaga, Miren, et al.
Publicado: (2023)

Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy
por: Nakamura, Ryotaro, et al.
Publicado: (2023)

ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes
por: Valentini, Caterina Giovanna, et al.
Publicado: (2021)

Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria
por: Araten, David J, et al.
Publicado: (2014)

Non-capsulated Neisseria meningitidis sepsis in a paroxysmal nocturnal hemoglobinuria patient treated with ravulizumab: case report and review of the literature
por: Galli, Nicole, et al.
Publicado: (2023)

Paroxysmal Nocturnal Hemoglobinuria (Pnh): Brain Mri Ischemic Lesions In Neurologically Asymtomatic Patients
por: Barcellini, Wilma, et al.
Publicado: (2018)

Anticoagulant therapy with rivaroxaban in a young patient with paroxysmal nocturnal hemoglobinuria
por: Dragoni, Francesco, et al.
Publicado: (2015)

Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Monitoring of Patients with Autoimmune Cytopenias during Sars-Cov-2 Vaccination Campaign: The Experience of a Reference Center
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The “Seed and Soil” Crosstalk
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature
por: Barcellini, Wilma, et al.
Publicado: (2021)

Autoimmune Complications in Hematologic Neoplasms
por: Barcellini, Wilma, et al.
Publicado: (2021)

P1725: OBSERVATIONAL STUDY TO EVALUATE PATIENT-REPORTED OUTCOMES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
por: Urciuoli, E., et al.
Publicado: (2022)

Secondary Hemophagocytic Lymphohistiocytosis and Autoimmune Cytopenias: Case Description and Review of the Literature
por: Fattizzo, Bruno, et al.
Publicado: (2021)

New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
por: Barcellini, Wilma, et al.
Publicado: (2020)

Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Bortezomib in autoimmune hemolytic anemia and beyond
por: Pasquale, Raffaella, et al.
Publicado: (2021)

Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Infectious Complications in Autoimmune Hemolytic Anemia
por: Giannotta, Juri Alessandro, et al.
Publicado: (2021)

Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia
por: Alessandro, Bosi, et al.
Publicado: (2022)

Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
por: Malagola, Michele, et al.
Publicado: (2023)

Early expression of CD94 and loss of CD96 on CD8+ T cells after allogeneic stem cell tranplantation is predictive of subsequent relapse and survival
por: Verma, Kriti, et al.
Publicado: (2022)

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
por: Lauener, Madeline P., et al.
Publicado: (2022)

A phase II, prospective, randomized, open-label study of defibrotide added to standard-of-care prophylaxis for the prevention of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation
por: Hudspeth, Michelle, et al.
Publicado: (2022)

Transcriptome analysis in acute gastrointestinal graft-versus host disease reveals a unique signature in children and shared biology with pediatric inflammatory bowel disease
por: Khandelwal, Pooja, et al.
Publicado: (2023)

Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up
por: Kim, Kyoung Ha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3qqke9s12425rp8jt0m3c46hj9